Thursday, October 28, 2021 1:13:08 PM
Our current phase of brine creation has focused on roasting with chloride salt use and distilled water use only in creating a very low impurity solution with a neutral to slightly basic pH solution. As such, early results show a potentially low capex, low environmental, and low carbon footprint for producing lithium carbonate.
The below table shows high-acid and non-acid solution ranges that will make up some of the first phase solutions now being prepared for shipping to the DOE in the nanotechnology Direct Lithium Exchange process (DLE) process:
Solution Type
PPM B
PPM Ca
PPM K
PPM Mg
PPM Na
PPM Li
Li/Mg Ratio
% Li into solution
High Acid pH 1.0
35
3,200
1,100
1,370
500
101
1/13.5
77.0
Non-Acid pH 6.8
BD
80
200
7
300
14
2.01/1
31.3
Note: BD is below the detection limit of 5 ppm. High acid solution ratio 1 part claystone to 9 parts high acid for 60min at 50c. Non-Acid solution 1 part roasted claystone 60min at 810c to 29 parts non-acid solution for 60min at 60c.
DLE uses different mediums of exchange to capture lithium ions while allowing other contaminant ions to pass by allowing for high purity capture of the lithium ions. We are providing a wide assortment of synthetic brine solutions to see how nanotechnology will handle the recovery of lithium ions. Many factors are involved in the ultimate economic recovery of lithium such as grade, recovery, reagent costs, energy costs, CO2 input costs.
One of the biggest benefits of lithium-hosted claystone deposits is the ability to make the lithium enriched solutions work with the DLE process. Resulting in the best possible economic and environmentally friendly recovery process possible in this rapidly expanding field.
"We have bookmarked the two ends of the spectrum to be used in the first series of solution tests, using the technology mentioned above. Throughout this project, and in the coming months, we will provide updates when results warrant," Stated President and CEO Robert McAllister."
History.htm
Recent ENRT News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:00:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/12/2024 08:02:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 01:02:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:04:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 07:23:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 01:06:20 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/01/2024 06:21:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 03:41:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/11/2024 08:38:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 06:24:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 02:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 02:02:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 09:09:35 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM